Researchers propose this mechanism could show selective toxicity toward cancer cells because: Tumor cells often lack catalase and other peroxide-neutralizing enzymes Cancer microenvironments contain elevated labile iron levels Normal cells maintain robust antioxidant defenses Clinical Trial Evidence Recent Phase II trials investigating vitamin C injections in cancer treatment have reported early signals that researchers describe as promising, though the evidence remains preliminary: Pancreatic Cancer Study: In a randomized Phase II trial of 34 patients with stage 4 metastatic pancreatic cancer led by Joseph Cullen at the University of IowaPharmacological ascorbate in combination with gemcitabine and nab-paclitaxel published in Redox Biology (2024)participants who received 75 grams (75,000 mg) of IV vitamin C three times weekly alongside standard chemotherapy reached a median overall survival of 16 months, compared with 8.3 months for chemotherapy alone
:quality(70)/https://assets.iprofesional.com/assets/jpg/2025/12/608597.jpg)
In May 2025, CheqUp, based in the UK, and WeightWatchers teamed up to offer clinical GLP-1 medication support along with behavioral lifestyle programs
Navy used HBOT to treat decompression sickness in deep-sea divers
Many pharmacies have pharmacists available to assess specific exposure scenarios and advise whether the medication is still suitable for use
Reconstitute MOTS-c in smaller volumes you can use within a week, or aliquot the reconstituted vial into freezer-safe containers for -20 C storage (2-3 months)
This could make you more susceptible to minor sniffles or cause your body to mimic the symptoms of a cold even when you are not actually sick